(Q36965049)

English

Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma

scientific article published on 07 October 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Y Mizukami

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

K Kono

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

T Maruyama

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

M Watanabe

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Y Kawaguchi

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

K Kamimura

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

H Fujii

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

0 references

publication date

7 October 2008

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

99

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1462-1467

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604715

0 references

Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

HLA typing demands for peptide-based anti-cancer vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

Clinical impact of HLA class I expression in rectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

Chemoradiation in the management of esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

29 September 2017

HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

27 June 2018

HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

4 September 2018

Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

4 September 2018

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579690

4 September 2018

HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/18841157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18841157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: association with early lymphatic spread of tumour cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18841157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and prognostic significance of immunoregulatory molecules in esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18841157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18841157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and prognostic significance of HLA class I, ICAM-1, and tumor-infiltrating lymphocytes in esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18841157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5

1 reference

https://pubmed.ncbi.nlm.nih.gov/18841157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Down-regulation of HLA class I antigen is an independent prognostic factor for clear cell renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18841157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/18841157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of HLA class I heavy chain expression in patients with gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18841157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18841157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6604715

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

release_vqsqynxmfngdrk7h2euf7wy3bq

1 reference

https://api.fatcat.wiki/v0/release/vqsqynxmfngdrk7h2euf7wy3bq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36965049&oldid=1844581863"